Results 181 to 190 of about 27,163 (253)

Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC/Nga mice

, 2015
Takumi Tsuji, Satoshi Okuno, Ayano Kuroda, Junya Hamazaki, Takuma Chikami, Sakura Sakurai, Yuya Yoshida, Rie Banno, Tetsuro Fujita, Takeyuki Kohno   +9 more
openalex   +1 more source

Safety and efficacy of oral cladribine in relapsing multiple sclerosis: a systematic review and meta-analysis. [PDF]

BMC Neurol
Alnajashi H, Almohammed HAJ, Morad AS, Bin Saddiq BW, Kushara KF, Al Zoabi BMK, Aldawsari WA, Almuhaysin FI, Gasim MA, Alharbi HA, Khan TN.   +10 more
europepmc   +1 more source

B-cell-driven relapse and anti-CD20 rescue therapy after Alemtuzumab in RRMS: case report and literature review. [PDF]

Front Immunol
Bruno PA, Barone S, Pascarella A, Lanza PL, Tinelli E, Gambardella A, Valentino P.   +6 more
europepmc   +1 more source

Depression, Anxiety, and MSQOL-54 Outcomes in RRMS Patients Receiving Fingolimod or Cladribine: A Cross-Sectional Comparative Study. [PDF]

Medicina (Kaunas)
Özbek M, Arıkanoğlu A, Aluçlu MU.
europepmc   +1 more source

Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study. [PDF]

J Neurol
Maniscalco GT, Sparaco M, Di Gregorio M, Cafasso G, Signoriello E, Romano F, Iodice R, Fantozzi R, Bellantonio P, Zanghi A, Sinisi L, D'Ambrosio A, Busillo V, Scarano V, Capuano R, Lavorgna L, Williams M, De Martino A, Di Battista ME, Di Giulio Cesare D, Lus G, Cassano E, Di Filippo PS, Sibilia G, Abbadessa G, Andreone V, Bonavita S.   +26 more
europepmc   +1 more source

Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis. [PDF]

Acta Neuropathol Commun
Husseini L, Geladaris A, Steinleitner MCJ, Häusler D, Weber MS.   +4 more
europepmc   +1 more source

Switch from fingolimod to ozanimod for safety or intolerance reasons. [PDF]

Ther Adv Neurol Disord
Signoriello E, Romano G, Foschi M, Zanghì A, D'Amico E, Fantozzi R, Centonze D, Lus G.   +7 more
europepmc   +1 more source

Fingolimod and changes in hematocrit, hemoglobin and red blood cells of patients with multiple sclerosis [Retraction].

, 2019

openalex   +1 more source

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

, 2017
Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir   +3 more
openalex   +1 more source

Evaluation of Selected Serum Adipocytokines in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Immunomodulatory Second-Line Drugs. [PDF]

Int J Mol Sci
Adamczyk B, Morawiec N, Kwinta R, Rakoca M, Wawrzyniak S, Zalejska-Fiolka J, Sowa A, Sawa K, Adamczyk-Sowa M.   +8 more
europepmc   +1 more source